Cargando…
Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson’s disease
There is a substantial amount of evidence from experimental parkinsonian models to show the neuroprotective effects of monoamine oxidase-B (MAOB) inhibitors. They have been studied for their potential disease-modifying effects in Parkinson’s disease (PD) for over 20 years in various clinical trials....
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847108/ https://www.ncbi.nlm.nih.gov/pubmed/24011391 http://dx.doi.org/10.1186/2047-9158-2-19 |